Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Brick › NPI 1962409987
Hospital

Meridian Hospitals Corporation

Meridian Hospitals Corporation was paid $4.72M by Medicaid between Jan 2018 and Jul 2018, across 162 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.

33Billing provider infoMERIDIAN HOSPITALS CORPORATION
BRICK, NJ 08724
33aNPI1962409987assigned 07/05/2005
28Total paid$4.72M
24GClaims64,397
24DCodes billed162
24AFirst – last monthJan 2018 – Jul 2018
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#65 of 93
Median peer was paid$30.60M
This provider vs. median0.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201864,397$4.72M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 32% 4,651 4,430 $1.51M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 2,924 2,698 $1.09M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7.1% 1,651 1,585 $337K
G0378 Hospital observation service, per hour 5.6% 313 265 $263K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.9% 2,454 592 $185K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.7% 702 676 $175K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.9% 66 43 $88K
96375 Therapeutic injection; each additional sequential IV push 1.5% 729 594 $73K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.2% 956 309 $54K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 73 73 $52K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1.1% 851 313 $50K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 67 28 $39K
150 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,733 $37K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 427 $37K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 4,020 $34K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 362 $32K
80053 Comprehensive metabolic panel <1% 3,105 $30K
70450 Computed tomography, head or brain; without contrast material <1% 559 $29K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 583 $27K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 164 $24K
77067 Screening mammography, bilateral, including computer-aided detection <1% 161 $17K
71046 Radiologic examination, chest; 2 views <1% 1,090 $17K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,059 $17K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 157 $15K
36415 Collection of venous blood by venipuncture <1% 2,669 $15K
OP279 <1% 633 $15K
84484 <1% 1,140 $14K
97010 <1% 1,480 $14K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 735 $13K
97162 <1% 163 $13K
96361 Intravenous infusion, hydration; each additional hour <1% 626 $13K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 14 $13K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 276 $13K
81003 <1% 2,073 $11K
71045 Radiologic examination, chest; single view <1% 594 $11K
78815 Positron emission tomography (PET) for limited area imaging <1% 12 $11K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 587 $11K
97161 <1% 112 $10K
OP379 <1% 144 $10K
80048 Basic metabolic panel (calcium, ionized) <1% 1,190 $9K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 105 $9K
97164 <1% 127 $8K
85610 <1% 1,023 $8K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $8K
84443 Thyroid stimulating hormone (TSH) <1% 317 $8K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 506 $8K
OP710 <1% 133 $7K
OP272 <1% 507 $7K
76830 Ultrasound, transvaginal <1% 148 $7K
36430 <1% 13 $7K
93971 <1% 132 $7K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 263 $7K
71250 <1% 44 $7K
93970 <1% 51 $7K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 100 $7K
76642 <1% 100 $6K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 123 $6K
OP259 <1% 3,265 $6K
71275 Computed tomographic angiography, chest, with contrast material <1% 93 $6K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 97 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 84 $5K
93975 <1% 80 $5K
80061 Lipid panel <1% 250 $5K
85730 <1% 658 $5K
87040 <1% 251 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 24 $4K
72110 <1% 128 $4K
96376 <1% 191 $4K
76536 <1% 57 $4K
72125 Computed tomography, cervical spine; without contrast material <1% 71 $4K
87088 <1% 462 $3K
85027 <1% 188 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 805 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 986 $3K
83880 <1% 162 $3K
J2060 Injection, lorazepam, 2 mg <1% 190 $3K
80076 <1% 413 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 132 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 137 $3K
83690 <1% 843 $2K
70551 Magnetic resonance imaging, brain; without contrast material <1% 12 $2K
74018 <1% 139 $2K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 55 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 120 $2K
73610 <1% 196 $2K
76775 <1% 42 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 16 $2K
73130 <1% 157 $2K
73562 <1% 132 $2K
72050 <1% 88 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 296 $2K
87070 <1% 810 $2K
82607 <1% 69 $2K
73630 <1% 215 $2K
73110 <1% 128 $2K
84439 <1% 115 $2K
87186 <1% 116 $2K
73030 <1% 166 $2K
83735 <1% 303 $2K
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 240 $1K
76801 <1% 13 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 372 $1K
77065 Tomosynthesis, mammo <1% 15 $1K
36591 <1% 47 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 180 $1K
84703 <1% 215 $1K
77063 Screening digital breast tomosynthesis, bilateral <1% 33 $1K
81025 <1% 420 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 194 $1K
86885 <1% 211 $1K
87205 <1% 87 $1K
85378 <1% 219 $1K
83605 <1% 43 $1K
83789 <1% 100 $1K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 12 $1K
84702 <1% 187 $1K
86900 <1% 261 $994.61
86901 <1% 263 $914.27
73140 <1% 107 $808.59
82248 <1% 131 $805.99
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 815 $734.59
97116 <1% 54 $725.85
85651 <1% 87 $696.12
90715 <1% 93 $688.95
86140 <1% 66 $660.96
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 12 $656.82
73564 <1% 44 $633.76
82746 <1% 13 $633.47
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 76 $621.97
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 76 $619.36
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 95 $600.89
73502 <1% 46 $574.10
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 366 $495.06
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 13 $492.08
74022 <1% 29 $421.35
87999 <1% 228 $374.20
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 30 $338.24
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 29 $338.24
J1644 Injection, heparin sodium, per 1000 units <1% 20 $304.00
82728 <1% 25 $297.10
86923 <1% 18 $275.28
72100 <1% 12 $273.48
97535 Self-care/home management training, each 15 minutes <1% 16 $258.47
87147 <1% 122 $253.50
86617 <1% 18 $209.42
82150 <1% 139 $204.74
73080 <1% 31 $184.19
86308 <1% 92 $174.10
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 89 $157.87
82550 <1% 40 $125.59
J7030 Infusion, normal saline solution , 1000 cc <1% 91 $109.55
74019 <1% 12 $83.25
J3010 Injection, fentanyl citrate, 0.1 mg <1% 103 $83.10
83550 <1% 14 $71.31
J2704 Injection, propofol, 10 mg <1% 107 $61.64
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 13 $23.00
J7510 Prednisolone oral, per 5 mg <1% 95 $15.00
84100 <1% 14 $14.60
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 13 $9.93
88313 0% 12 $0.00
73590 0% 13 $0.00
88342 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGANTNER, JOHN (SENIOR VP, FINANCE & CFO)
Same official

Other billing entities under GANTNER, JOHN

Full network →
ProviderLocationPaid
Meridian Hospitals CorporationNeptune, NJ$11.83M
Meridian Hospitals CorporationRed Bank, NJ$2.31M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.